MicroRNA-127 and MicroRNA-132 Expression in Patients with Methamphetamine Abuse in East Azerbaijan, Iran: A Case-Control Study

Background: Addiction is a personal and social problem worldwide, and has physical and psychological effects on consumers’ health. Recently, miRNAs have been described as noninvasive biomarkers. Currently, methamphetamine abuse (MA) is mainly diagnosed by chromatography. This study aimed to investig...

Full description

Bibliographic Details
Main Authors: Saman Rezai Moradali, Hossein Soltanzadeh, Hassan Montazam, Zahra Asadi, Shima Fathi
Format: Article
Language:English
Published: Kerman University of Medical Sciences 2022-07-01
Series:Addiction and Health
Subjects:
Online Access:https://ahj.kmu.ac.ir/article_92054_bdf86a53c932a986df4fbbdc6e430cca.pdf
_version_ 1827825344678199296
author Saman Rezai Moradali
Hossein Soltanzadeh
Hassan Montazam
Zahra Asadi
Shima Fathi
author_facet Saman Rezai Moradali
Hossein Soltanzadeh
Hassan Montazam
Zahra Asadi
Shima Fathi
author_sort Saman Rezai Moradali
collection DOAJ
description Background: Addiction is a personal and social problem worldwide, and has physical and psychological effects on consumers’ health. Recently, miRNAs have been described as noninvasive biomarkers. Currently, methamphetamine abuse (MA) is mainly diagnosed by chromatography. This study aimed to investigate the expression and diagnostic value of miR-127 and miR-132 in blood samples of patients with MA and non-user healthy controls. Methods: A total of 60 patients with MA (case group) and 60 non-user healthy individuals (control group) were selected from Tabriz, East Azerbaijan, Iran. Peripheral blood was obtained and total RNA was extracted. Then, cDNA synthesis was performed and miR-127 and miR-132 expression was evaluated using real time polymerase chain reaction (PCR) method. Findings: The results of this study demonstrated that miR-127 was significantly lower (0.042-fold change) in patients with MA than in the control group (P<0.05). However, miR-132 was significantly higher (7.1-fold change) in patients with MA than in the control group (P<0.05). Conclusion: In general, expression of miR-127 and miR-132 may alter in patients with MA. Further studies are needed to identify underlying molecular mechanisms in patients with MA.
first_indexed 2024-03-12T02:47:44Z
format Article
id doaj.art-e81c477ae6664ced8156f1ac6a288d61
institution Directory Open Access Journal
issn 2008-4633
2008-8469
language English
last_indexed 2024-03-12T02:47:44Z
publishDate 2022-07-01
publisher Kerman University of Medical Sciences
record_format Article
series Addiction and Health
spelling doaj.art-e81c477ae6664ced8156f1ac6a288d612023-09-04T06:42:11ZengKerman University of Medical SciencesAddiction and Health2008-46332008-84692022-07-011432141710.34172/ahj.2022.129892054MicroRNA-127 and MicroRNA-132 Expression in Patients with Methamphetamine Abuse in East Azerbaijan, Iran: A Case-Control StudySaman Rezai Moradali0Hossein Soltanzadeh1Hassan Montazam2Zahra Asadi3Shima Fathi4Department of Genetics, Bonab Branch, Islamic Azad University, Bonab, Iran1. Department of Genetics, Bonab Branch, Islamic Azad University, Bonab, Iran 2. Medicinal Plants Research Center, Maragheh University of Medical Sciences, Maragheh, IranDepartment of Genetics, Bonab Branch, Islamic Azad University, Bonab, IranDepartment of Genetics, Bonab Branch, Islamic Azad University, Bonab, IranDepartment of Genetics, Bonab Branch, Islamic Azad University, Bonab, IranBackground: Addiction is a personal and social problem worldwide, and has physical and psychological effects on consumers’ health. Recently, miRNAs have been described as noninvasive biomarkers. Currently, methamphetamine abuse (MA) is mainly diagnosed by chromatography. This study aimed to investigate the expression and diagnostic value of miR-127 and miR-132 in blood samples of patients with MA and non-user healthy controls. Methods: A total of 60 patients with MA (case group) and 60 non-user healthy individuals (control group) were selected from Tabriz, East Azerbaijan, Iran. Peripheral blood was obtained and total RNA was extracted. Then, cDNA synthesis was performed and miR-127 and miR-132 expression was evaluated using real time polymerase chain reaction (PCR) method. Findings: The results of this study demonstrated that miR-127 was significantly lower (0.042-fold change) in patients with MA than in the control group (P<0.05). However, miR-132 was significantly higher (7.1-fold change) in patients with MA than in the control group (P<0.05). Conclusion: In general, expression of miR-127 and miR-132 may alter in patients with MA. Further studies are needed to identify underlying molecular mechanisms in patients with MA.https://ahj.kmu.ac.ir/article_92054_bdf86a53c932a986df4fbbdc6e430cca.pdfaddictionmethamphetaminemicrorna-127microrna-132biomarker
spellingShingle Saman Rezai Moradali
Hossein Soltanzadeh
Hassan Montazam
Zahra Asadi
Shima Fathi
MicroRNA-127 and MicroRNA-132 Expression in Patients with Methamphetamine Abuse in East Azerbaijan, Iran: A Case-Control Study
Addiction and Health
addiction
methamphetamine
microrna-127
microrna-132
biomarker
title MicroRNA-127 and MicroRNA-132 Expression in Patients with Methamphetamine Abuse in East Azerbaijan, Iran: A Case-Control Study
title_full MicroRNA-127 and MicroRNA-132 Expression in Patients with Methamphetamine Abuse in East Azerbaijan, Iran: A Case-Control Study
title_fullStr MicroRNA-127 and MicroRNA-132 Expression in Patients with Methamphetamine Abuse in East Azerbaijan, Iran: A Case-Control Study
title_full_unstemmed MicroRNA-127 and MicroRNA-132 Expression in Patients with Methamphetamine Abuse in East Azerbaijan, Iran: A Case-Control Study
title_short MicroRNA-127 and MicroRNA-132 Expression in Patients with Methamphetamine Abuse in East Azerbaijan, Iran: A Case-Control Study
title_sort microrna 127 and microrna 132 expression in patients with methamphetamine abuse in east azerbaijan iran a case control study
topic addiction
methamphetamine
microrna-127
microrna-132
biomarker
url https://ahj.kmu.ac.ir/article_92054_bdf86a53c932a986df4fbbdc6e430cca.pdf
work_keys_str_mv AT samanrezaimoradali microrna127andmicrorna132expressioninpatientswithmethamphetamineabuseineastazerbaijaniranacasecontrolstudy
AT hosseinsoltanzadeh microrna127andmicrorna132expressioninpatientswithmethamphetamineabuseineastazerbaijaniranacasecontrolstudy
AT hassanmontazam microrna127andmicrorna132expressioninpatientswithmethamphetamineabuseineastazerbaijaniranacasecontrolstudy
AT zahraasadi microrna127andmicrorna132expressioninpatientswithmethamphetamineabuseineastazerbaijaniranacasecontrolstudy
AT shimafathi microrna127andmicrorna132expressioninpatientswithmethamphetamineabuseineastazerbaijaniranacasecontrolstudy